Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
+10.2%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$75.7B
AUM Growth
+$5.05B
(+7.1%)
Cap. Flow
-$768M
Cap. Flow
% of AUM
-1.02%
Top 10 Holdings %
Top 10 Hldgs %
19.03%
Holding
4,401
New
229
Increased
2,004
Reduced
1,934
Closed
153
Top Buys
Top Sells
| 1 |
Apple
AAPL
|
$131M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$66.8M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$64.3M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$50.2M |
| 5 |
SPDR Gold Trust
GLD
|
$46.3M |
Sector Composition
| 1 | Technology | 12.53% |
| 2 | Financials | 5.31% |
| 3 | Consumer Discretionary | 3.9% |
| 4 | Industrials | 3.15% |
| 5 | Healthcare | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4026
United Microelectronic
UMC
$17.1B
| $123K | ﹤0.01% |
16,120
-2,782
| -15% | -$21.2K |
|
4027
Innoviz Technologies
INVZ
$317M
| $122K | ﹤0.01% |
74,281
+130
| +0.2% | +$214 |
|
4028
CytomX Therapeutics
CTMX
$376M
| $121K | ﹤0.01% |
53,243
-1,000
| -2% | -$2.27K |
|
4029
Equinox Gold
EQX
$7.65B
| $121K | ﹤0.01% |
21,108
-8,400
| -28% | -$48.2K |
|
4030
PDS Biotechnology
PDSB
$56.4M
| $121K | ﹤0.01% |
90,672
-1,358
| -1% | -$1.81K |
|
4031
NCR Voyix
VYX
$1.84B
| $120K | ﹤0.01% |
10,223
-5,141
| -33% | -$60.3K |
|
|
ACB
4032
Aurora Cannabis
ACB
$272M
| $119K | ﹤0.01% |
28,040
-135
| -0.5% | -$573 |
|
4033
Quanterix
QTRX
$211M
| $119K | ﹤0.01% |
17,915
-100
| -0.6% | -$664 |
|
4034
Greystone Housing Impact Investors LP
GHI
$253M
| $118K | ﹤0.01% |
+10,443
| New | +$118K |
|
4035
Monogram Orthopaedics
MGRM
$232M
| $118K | ﹤0.01% |
40,857
-358
| -0.9% | -$1.03K |
|
4036
Fortuna Silver Mines
FSM
$2.35B
| $117K | ﹤0.01% |
17,893
-4,204
| -19% | -$27.5K |
|
4037
ASE Group
ASX
$22.8B
| $116K | ﹤0.01% |
11,255
-2,197
| -16% | -$22.6K |
|
|
EOD
4038
Allspring Global Dividend Opportunity Fund
EOD
$246M
| $115K | ﹤0.01% |
21,281
| – | – |
|
|
CEV
4039
Eaton Vance California Municipal Income Trust
CEV
$66.8M
| $114K | ﹤0.01% |
11,727
| – | – |
|
|
EDAP
4040
EDAP TMS
EDAP
$94.2M
| $114K | ﹤0.01% |
69,160
| – | – |
|
4041
Fortress Biotech
FBIO
$110M
| $114K | ﹤0.01% |
61,527
+30
| +0% | +$56 |
|
4042
InflaRx
IFRX
$112M
| $114K | ﹤0.01% |
144,000
+37,500
| +35% | +$29.7K |
|
4043
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$642M
| $113K | ﹤0.01% |
11,734
+1,373
| +13% | +$13.2K |
|
4044
BlackRock MuniVest Fund
MVF
$376M
| $112K | ﹤0.01% |
17,084
+100
| +0.6% | +$656 |
|
4045
Voyager Therapeutics
VYGR
$235M
| $112K | ﹤0.01% |
35,950
-31,374
| -47% | -$97.7K |
|
4046
Cullinan Oncology
CGEM
$413M
| $111K | ﹤0.01% |
14,699
-461
| -3% | -$3.48K |
|
|
EAD
4047
Allspring Income Opportunities Fund
EAD
$421M
| $111K | ﹤0.01% |
15,748
+183
| +1% | +$1.29K |
|
4048
Nuveen California Municipal Value Fund
NCA
$284M
| $111K | ﹤0.01% |
+12,800
| New | +$111K |
|
|
CIK
4049
Credit Suisse Asset Management Income Fund
CIK
$163M
| $110K | ﹤0.01% |
37,272
+11,963
| +47% | +$35.3K |
|
|
GLQ
4050
Clough Global Equity Fund
GLQ
$139M
| $110K | ﹤0.01% |
15,389
-1,250
| -8% | -$8.94K |
|